Market Analysis
Auto Added by WPeMatico
Auto Added by WPeMatico
Icebreaker claims to be Finland’s most active pre-seed VC. The firm, which also invests in Estonia and Sweden, has backed 38 companies in the last three years out of its first fund, with a 65% success rate so far for companies that have been able to raise follow-on funding.
Two weeks ago, Icebreaker announced the launch of Fund II, with an initial close of €50 million. That’s more than twice the size of its first fund, which topped out at €20 million.
Its remit remains largely the same, however. The company typically invests between €150k and €800k in teams that have “deep domain expertise” and are building globally competitive tech companies according to Icebreaker co-founder and partner Riku Seppälä.
Noteworthy, this goes right to the top of the funnel and includes backing and helping to connect “pre-founders,” defined as individuals with over 5 years of work experience in their domain who are aiming to start or join a tech company. As part of this effort, Icebreaker operates an online and offline community to act as a catalyst for new companies to be founded.
Meanwhile, I’m told that Fund II was signed just as the coronavirus crisis began to take hold and includes the majority of LPs from Fund I in addition to new investors. Lead LPs are Tesi, KRR III, Varma Mutual Pension Insurance Company and Elo Mutual Pension Insurance Company, together with 41 other entities consisting of institutional investors, family offices and founders.
To find out more about Fund II and what’s it’s like to launch a new pre-seed fund at a time of such uncertainty, and to understand how Icebreaker thinks about startup life during and after lockdown, I put questions to Icebreaker co-founder and Partner Riku Seppälä.
TechCrunch: What does it feel like to close a new fund right at the start of a pandemic?
Riku Seppälä: Of course, we have been distracted by the mounting health crisis and how the world economy will recover, so the feelings are mixed.
Powered by WPeMatico
Ransomware is getting sneakier and smarter.
The latest example comes from ExecuPharm, a little-known but major outsourced pharmaceutical company that confirmed it was hit by a new type of ransomware last month. The incursion not only encrypted the company’s network and files, hackers also exfiltrated vast amounts of data from the network. The company was handed a two-for-one threat: pay the ransom and get your files back or don’t pay and the hackers will post the files to the internet.
This new tactic is shifting how organizations think of ransomware attacks: it’s no longer just a data-recovery mission; it’s also now a data breach. Now companies are torn between taking the FBI’s advice of not paying the ransom or the fear their intellectual property (or other sensitive internal files) are published online.
Because millions are now working from home, the surface area for attackers to get in is far greater than it was, making the threat of ransomware higher than ever before.
That’s just one of the stories from the week. Here’s what else you need to know.
Education giant Chegg confirmed its third data breach in as many years. The latest break-in affected past and present staff after a hacker made off with 700 names and Social Security numbers. It’s a drop in the ocean when compared to the 40 million records stolen in 2018 and an undisclosed number of passwords taken in a breach at Thinkful, which Chegg had just acquired in 2019.
Those 700 names account for about half of its 1,400 full-time employees, per a filing with the Securities and Exchange Commission. But Chegg’s refusal to disclose further details about the breach — beyond a state-mandated notice to the California attorney general’s office — makes it tough to know exactly went wrong this time.
Powered by WPeMatico
The COVID-19 crisis is creating an untold amount of uncertainty through every business sector, but for cannabis startups, it’s exacerbating a critical market that was already in decline.
TechCrunch spoke to Schwazze CEO Justin Dye following his company’s recent rebrand. He joined the company when it was Colorado’s Medicine Man Technologies (MMT) in late 2019 and is revamping the organization, including changing its name to Schwazze and acquiring a handful of companies to create a healthier, vertically integrated cannabis company.
The cannabis market is experiencing a correction after a period of rapid expansion. Shops are feeling the pain, and public valuations are settling under IPO levels — and this was before a pandemic swept the world. Cannabis media outlet Leafly laid off 91 employees in late March, and Eaze, an early mover in on-demand pot delivery, is experiencing major trouble after raising serious cash and recently losing a top partner in Caliva. In several states, efforts are underway to prop up the cannabis market by asking for the federal government to allow these businesses to be eligible for federal financial relief.
According to Dye, there are several things CEOs of cannabis companies of every size should work toward. His advice echoes what TechCrunch has heard in other verticals, as well: During the COVID-19 crisis, cannabis companies must hunker down and lean on strong teams to weather the storm. Once the skies start to clear, capital will be available to the survivors.
One, the cannabis market is looking for financially sustainable companies, Dye said.
“This next reset in the cannabis industry will not only be aspirational, but it’s going to be coupled with a requirement for performance in terms of executing against a plan and driving profits — or driving it to create free cash flow to be reinvested in the business and product experiences.”
Powered by WPeMatico
Quarter after quarter, familiar stories have appeared. The smartphone market, once seemingly bulletproof, has suffered. The list of factors is long, and I’ve written about them ad nauseam here, but the CliffsNotes version is: costs are too high, innovation is too incremental and most people already own a device that will be plenty good for the next few years.
But 2020 was going to be different. Smartphone makers were set to finally give consumers a reason to upgrade in the form of 5G. The first handsets appeared in earnest last year, but between a much wider carrier roll out, lower-cost 5G radios from Qualcomm and the arrival of a 5G iPhone, this was going to be the year the next-gen wireless technology helped reverse the smartphone slide.
And then COVID-19 disrupted everything. For many of us, life is on hold — and will likely continue to be for months. I’m writing this from my home in Queens, N.Y., the hardest-hit county in the hardest-hit country in the world. It still feels strange to type that, even though it’s been a reality for a month and half now.
Purchasing a smartphone is most likely the last thing on anyone’s mind during what is shaping up to be the worst global pandemic since the 1918 flu pandemic. With a number of key manufacturers reporting quarterly earnings this week, the numbers are starting to bear out this disconnect. Earlier this week, both Samsung and LG reported weak mobile numbers. Yesterday, Apple reported revenue of $28.96 billion, down from $31.1 billion the same time last year.
More troubling, all three companies appeared to be united in suggesting that the worst might be yet to come. Samsung suggested that both mobile and TV demand would “decline significantly” in the following quarter. LG used virtually the same exact wording, stating that, “market demand is expected to decline significantly YoY due to COVID-19 pandemic.” For its part, Apple simply didn’t issue guidance for the next quarter, a surefire indication of uncertainty in these uncertain times — to borrow a phrase from every commercial airing currently.
Powered by WPeMatico
Back in January, Georgia Tech professor David Joyner got a cryptic email from a student based in Wuhan, China.
“I’m under quarantine, but my internet access is okay so I have more time to spend on classwork, I wanted to let you know,” the message read. Unsure why Wuhan would be under quarantine, Joyner did a quick Google search and saw the beginnings of the coronavirus pandemic.
“I thought, there’s something going on in Wuhan so maybe we’ll have some students affected by it,” Joyner said. Fast-forward two months and the coronavirus is a household term. All of Joyner’s students, regardless of geography, have been impacted by the pandemic.
It has been a little over a month since colleges and schools across the country started shutting down due to COVID-19. Edtech startups had a surge in usage and a demand for more resources than ever. Now that the adoption scramble has slowed, the same startups are reckoning with unprecedented use cases.
Everyone knows how they’re expected to behave in a physical classroom, but can you stop a student from cheating when taking a test in their bedroom at home? How should teachers offer 1:1 time and take questions during a lesson?
Piazza founder Pooja Sankar says teachers face more open questions: “What does it mean to record myself? What does it mean to have a camera on my face? How do I know I can hold a class with reliable internet connection?”
Powered by WPeMatico
Edtech was long defined by stodgy sales cycles, sluggish adoption and splashy pitches to K-12 districts with tight budgets, but the COVID-19 pandemic turned that reputation on its head in short order.
Now, companies in the space are entering Q2 — traditionally a slower time reserved for product development and extra focus on existing clients — busier than ever. In this piece, we’ll unpack some of the dollar signs indicating that edtech may be entering a new era.
A number of edtech founders who are not seeking venture capital have recently told me their inboxes are cluttered with notes from investors looking to chat.
It’s a refreshing break from the usual fundraising doom-and-gloom we’ve been hearing about during this pandemic, but I want to note the nuance: We’re seeing investors who have never been interested in edtech become bullish on the category as a whole. If these investors put their money where their mouths are, we’ll start to see an uptick of venture funding sector-wide.
For EdSights, co-founded by sister duo Claudia and Carolina Recchi, doors are opening. Before COVID-19, they say they mainly attracted interest from opportunity investors and edtech investors. Now, they’re talking to a number of VCs, none solely from edtech-focused funds.
Powered by WPeMatico
Earlier this month, href=”https://www.zettavp.com/”>Zetta Venture Partners, a B2B, AI-focused venture outfit, announced a new $180 million fund.
As new VC funds are anecdotally a bit thinner on the ground these days — and because we’re in the midst of economic upheaval, which is changing investing patterns and shaking up startup verticals — I got on the phone with Zetta’s Jocelyn Goldfein (a TechCrunch regular) to chat about what her firm is doing and what’s up with AI investing.
Zetta’s new fund is about 50% larger than its preceding capital pool, which was roughly double its first fund. If you don’t want to do the math, Zetta’s first fund was worth $60 million, and its second $125 million.
Zetta will invest in B2B-focused, AI-powered seed-stage startups like it has before, but with more capital. I was curious about cadence: Would the firm write more checks more quickly now that it has more capital? Per Goldfein, the firm is keeping its pace and strategy pretty much the same with preceding funds, though it has promoted a principal from within who will begin to lead deals from the new fund.
Why more money if things are mostly looking the same? Zetta wants the capability to write larger checks and take a bit more ownership, so it needs more capital. In turn, defending those percentages requires more capital; you get the idea.
Early in our chat with Goldfein it became obvious that it’s an active time for AI-focused startups to raise, thanks to COVID-19-driven uncertainty. According to Goldfein, founders who have yet to raise their first capital are “looking at the funding window and thinking, oh, boy, if we thought we might raise three months from now, maybe we should just try now.” Even more, some companies that have already raised are going back to the market for top-ups. Goldfein said those startups are looking for “a little extra runway.”
Powered by WPeMatico
An emergency room physician for the past 12 years, Dr. Robert Mittendorff joined Norwest Venture Partners eight years ago as a healthcare investor; the firm invests in a number of healthcare startups, including Talkspace, which raised a $50 million Series D last year, and TigerConnect.
As the COVID-19 pandemic spreads, Mittendorff is spending his weekdays with portfolio companies and weekends working with Kaiser Permanente in San Francisco. While he notes that his medical colleagues are “bearing the brunt” of the pandemic by working full time, we wanted to hear from someone who has a foot in both the investing and the healthcare world right now.
In this interview, he discusses what he’s learned from both roles, how it has influenced his healthcare investments, and offers his predictions regarding which companies will fare the best in the future.
This interview has been edited for length and clarity.
TechCrunch: How did you get to where you are today?
Dr. Robert Mittendorff: So, my journey to being a venture capitalist at Norwest and investing in healthcare companies as well as an emergency physician was really a parallel set of paths that overlapped and that cross every once in a while and now usually on a daily basis.
I started off life as a biomedical engineer really focused on wanting to be on the side of innovation and on the development of technologies to help human health. I knew early on that I wanted to be on the business side [of that], but it was important for me to understand and really be deeply in touch with what it was like to be a provider.
The journey started out going to engineering school, medical school, and then business school in the middle of medical school. I trained at Stanford, which really exposed me to county hospitals, which are probably going to be the more challenging situations as the weeks go on here, and then to Kaiser Permanente. And then, of course, Stanford, I was exposed to San Francisco General and then the Santa Clara Valley Hospital. I always practice part-time following up so it’s been 12 years as an attending, practicing part-time as an emergency physician.
In the venture space I saw an opportunity to really help select entrepreneurs and markets to grow them to a higher impact state.
Powered by WPeMatico
Security startups to the rescue.
As we continue to ride out the pandemic, security experts are closely monitoring the surge of coronavirus-related cyber threats. Just this week, Google’s Threat Analysis Group, its elite threat hunting unit, says that while the overall number of threats remains largely the same, opportunistic hackers are retooling their efforts to piggyback on coronavirus.
Some startups are downsizing and laying off staff, but several cybersecurity startups are faring better, thanks to an uptick in demand for security protections. As the world continues to pivot toward working from home, it has blown up key cybersecurity verticals in ways we never expected. To wit, identity startups are needed more than ever to make sure only remote employees are getting access to corporate systems.
Can the startups take on the giants at their own game?
For the third time this year, a payments processor has admitted to a security lapse. First it was Cornerstone, then it was nCourt. This time it’s Paay, a New York-based card payment processor startup that left a database on the internet unprotected and without a password. Worse, the data was storing full, plaintext credit card numbers.
Anyone who knew where to look could have accessed the data. Luckily, a security researcher found it and reported it to TechCrunch. We alerted the company; it quickly took the data offline, but Paay denied that the data stored full credit card numbers. We even sent the co-founder a portion of the data showing card numbers stored in plaintext, but he did not respond to our follow-up.
Powered by WPeMatico
Matt Ocko, co-founder of venture firm Data Collective (DCVC), was among a small group of VCs viewed as alarmists when they began tweeting about the coronavirus’s imminent appearance in the U.S. back in January.
In retrospect, those individuals were prescient, so we spoke with Ocko last week about why he was so certain the U.S. was about to get walloped by COVID-19, and asked how some of the startups in DCVC’s portfolio — which has long had a strong biotech focus — are trying to get us back to a state of normalcy.
This conversation has been edited for length.
TechCrunch: You were tweeting about COVID-19 back in January; I almost canceled a flight out of San Francisco because of your [expressed concern about a flight bound for SFO from Wuhan, China]. What did you see that the rest of us missed?
Matt Ocko: My family has been working with the Chinese government at a reasonably high level since the late 1970s, starting with my dad, and I kind of grew up in that environment. And at a relatively young age, as a professional [in the 1990s], I started pro bono helping my dad, who’s a Chinese legal expert, on things like constructing the laws around China’s Nasdaq equivalent, its stock markets, the joint dollar-renminbi investment legislation, advice on technology development and venture capital development.
I’m not an anti-China hawk by any means. But I do have an understanding of some of the idiosyncrasies of Chinese culture reflected in its government, the same way every country has its idiosyncrasies.
[In China’s case], it’s a focus on face and reputation and extreme sensitivity to negative perception or shame or humiliation at every level of government and culture. And so there’s [an] unfortunate trend — and not a universal one — for people to manage upwards, especially in the government, and tell their higher-ups what they want to hear to avoid shame, to avoid the loss of reputation and to kick the can down the road or hope that circumstances on the ground change favorably in the face of denial or equivocation.
Powered by WPeMatico